306 related articles for article (PubMed ID: 37095343)
21. Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients.
Zhang R; Shin BH; Gadsden TM; Petrosyan A; Vo A; Ammerman N; Sethi S; Huang E; Peng A; Najjar R; Atienza J; Kim I; Jordan SC
Transpl Infect Dis; 2022 Apr; 24(2):e13813. PubMed ID: 35202497
[TBL] [Abstract][Full Text] [Related]
22. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
[TBL] [Abstract][Full Text] [Related]
24. Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients.
Affeldt P; Koehler FC; Brensing KA; Gies M; Platen E; Adam V; Butt L; Grundmann F; Heger E; Hinrichs S; Kalisch N; Oehm S; Steger G; Wirtz M; Benzing T; Stippel D; Klein F; Kurschat C; Müller RU; Di Cristanziano V
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560648
[TBL] [Abstract][Full Text] [Related]
25. Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2.
Speer C; Göth D; Benning L; Buylaert M; Schaier M; Grenz J; Nusshag C; Kälble F; Kreysing M; Reichel P; Töllner M; Hidmark A; Ponath G; Schnitzler P; Zeier M; Süsal C; Morath C; Klein K
Clin J Am Soc Nephrol; 2021 Jul; 16(7):1073-1082. PubMed ID: 34031181
[TBL] [Abstract][Full Text] [Related]
26. Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring.
Crespo M; Barrilado-Jackson A; Padilla E; Eguía J; Echeverria-Esnal D; Cao H; Faura A; Folgueiras M; Solà-Porta E; Pascual S; Barbosa F; Hurtado S; Ribera L; Río-No L; Pérez-Sáez MJ; Redondo-Pachón D; Pascual J
Am J Transplant; 2022 Mar; 22(3):786-800. PubMed ID: 34551187
[TBL] [Abstract][Full Text] [Related]
27. Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients.
Yasar E; Yildiz Y; Ozturk E; Gok Oguz E; Coskun Yenigun E; Ozturk R; Helvaci O; Ozger HS; Keles M; Karacin C; Ugras Dikmen A; Caglar K; Duranay M; Ayli MD; Dizbay M; Erten Y; Guz G; Derici U
Nephrology (Carlton); 2024 Jul; 29(7):405-414. PubMed ID: 38485143
[TBL] [Abstract][Full Text] [Related]
28. The humoral immune response to the BNT 162B2 vaccine in pediatrics on renal replacement therapy.
Alshami A; Bahbah H; Al Attas R; Aldokhi F; Azzam A
Pediatr Transplant; 2024 May; 28(3):e14712. PubMed ID: 38553800
[TBL] [Abstract][Full Text] [Related]
29. Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis.
Yoshifuji A; Toda M; Ryuzaki M; Kikuchi K; Kawai T; Sakai K; Oyama E; Koinuma M; Katayama K; Uehara Y; Ohmagari N; Kanno Y; Kon H; Shinoda T; Takano Y; Tanaka J; Hora K; Nakazawa Y; Hasegawa N; Hanafusa N; Hinoshita F; Morikane K; Wakino S; Nakamoto H; Takemoto Y
Ren Replace Ther; 2022; 8(1):39. PubMed ID: 35999867
[TBL] [Abstract][Full Text] [Related]
30. Dialysis modality, humoral response to vaccine, and SARS-CoV-2 infection risk: Comparative prospective evaluation.
Bnaya A; Nacasch N; Einbinder Y; Shavit L; Erez D; Shashar M; Grupper A; Benchetrit S; Wand O; Cohen-Hagai K
Semin Dial; 2023; 36(5):382-389. PubMed ID: 37042666
[TBL] [Abstract][Full Text] [Related]
31. Torquetenovirus viral load is associated with anti-spike antibody response in SARS-CoV-2 mRNA BNT162b2 vaccinated kidney transplant patients.
Querido S; Adragão T; Pinto I; Ormonde C; Papoila AL; Pessanha MA; Gomes P; Ferreira S; Figueira JM; Cardoso C; Viana JF; Weigert A
Clin Transplant; 2022 Dec; 36(12):e14825. PubMed ID: 36301197
[TBL] [Abstract][Full Text] [Related]
32. COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study.
Sauré D; O'Ryan M; Torres JP; Zuñiga M; Soto-Rifo R; Valiente-Echeverría F; Gaete-Argel A; Neira I; Saavedra V; Acevedo ML; Archila C; Acuña F; Rain M; Basso LJ
Lancet Microbe; 2023 Mar; 4(3):e149-e158. PubMed ID: 36716754
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.
Bruminhent J; Setthaudom C; Kitpermkiat R; Kiertiburanakul S; Malathum K; Assanatham M; Nongnuch A; Phuphuakrat A; Chaumdee P; Janphram C; Thotsiri S; Chuengsaman P; Boongird S
Sci Rep; 2022 Mar; 12(1):3587. PubMed ID: 35246578
[TBL] [Abstract][Full Text] [Related]
34. Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.
Gonzalez-Perez M; Montes-Casado M; Conde P; Cervera I; Baranda J; Berges-Buxeda MJ; Perez-Olmeda M; Sanchez-Tarjuelo R; Utrero-Rico A; Lozano-Ojalvo D; Torre D; Schwarz M; Guccione E; Camara C; Llópez-Carratalá MR; Gonzalez-Parra E; Portoles P; Ortiz A; Portoles J; Ochando J
Front Immunol; 2022; 13():845882. PubMed ID: 35401504
[TBL] [Abstract][Full Text] [Related]
35. Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.
Haase M; Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos-Araújo C; Veiga PM; Macario F
J Nephrol; 2022 Jun; 35(5):1467-1478. PubMed ID: 35084719
[TBL] [Abstract][Full Text] [Related]
36. Humoral response to vaccination against SARS-CoV-2 in patients undergoing dialysis.
Lee YJ; Park BS; Heo CM; Park S; Yu S; Kim YW
Medicine (Baltimore); 2022 Dec; 101(50):e32152. PubMed ID: 36550899
[TBL] [Abstract][Full Text] [Related]
37. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
Front Immunol; 2022; 13():827306. PubMed ID: 35173736
[TBL] [Abstract][Full Text] [Related]
38. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
39. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
Zitt E; Davidovic T; Schimpf J; Abbassi-Nik A; Mutschlechner B; Ulmer H; Benda MA; Sprenger-Mähr H; Winder T; Lhotta K
Front Immunol; 2021; 12():704773. PubMed ID: 34220867
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
